Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Gushen Biological Technology Group is a leading Chinese industrial enterprise specializing in the deep processing of non-GMO soybeans into high-value nutritional and functional ingredients. The company is one of the world's largest producers of soy protein isolates, concentrates, and textured vegetable proteins, serving the food, beverage, and pharmaceutical industries. By leveraging advanced biological extraction technologies, Gushen Group produces essential components for clinical nutrition, infant formula, and sports supplements. Their operations span the entire value chain, from soybean crushing and oil refining to the manufacturing of specialized soy fibers and proteins. Headquartered in Dezhou, Shandong, the group exports its products to over 60 countries across Europe, North America, and Asia. The company plays a critical role in the global plant-based protein market, supporting the development of sustainable and health-focused food products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gushen Biological Technology Group.